pargyline has been researched along with Leukemia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menna, M | 1 |
| Fiorentino, F | 1 |
| Marrocco, B | 1 |
| Lucidi, A | 1 |
| Tomassi, S | 1 |
| Cilli, D | 1 |
| Romanenghi, M | 1 |
| Cassandri, M | 1 |
| Pomella, S | 1 |
| Pezzella, M | 1 |
| Del Bufalo, D | 1 |
| Zeya Ansari, MS | 1 |
| Tomašević, N | 1 |
| Mladenović, M | 1 |
| Viviano, M | 1 |
| Sbardella, G | 1 |
| Rota, R | 1 |
| Trisciuoglio, D | 1 |
| Minucci, S | 1 |
| Mattevi, A | 1 |
| Rotili, D | 1 |
| Mai, A | 1 |
1 other study available for pargyline and Leukemia
| Article | Year |
|---|---|
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
Topics: Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia | 2022 |